1. Home
  2. GSUN vs OGEN Comparison

GSUN vs OGEN Comparison

Compare GSUN & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

HOLD

Current Price

$0.41

Market Cap

3.3M

Sector

Real Estate

ML Signal

HOLD

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.58

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSUN
OGEN
Founded
1997
1996
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
2.8M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
GSUN
OGEN
Price
$0.41
$0.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5M
39.4K
Earning Date
02-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$0.50
52 Week High
$3.31
$1.49

Technical Indicators

Market Signals
Indicator
GSUN
OGEN
Relative Strength Index (RSI) 49.12 45.73
Support Level $0.35 $0.56
Resistance Level $0.55 $0.64
Average True Range (ATR) 0.06 0.03
MACD -0.00 -0.00
Stochastic Oscillator 47.48 36.94

Price Performance

Historical Comparison
GSUN
OGEN

About GSUN Golden Sun Education Group Limited

Golden Sun Technology Group Ltd operates two principal lines of business: tutorial services and e-commerce services. The company's e-commerce operations currently consist of data analytics-driven marketing and social media promotional services for small and medium-sized businesses on short video platforms based in China. The company's education centers offer two main programs, comprising of foreign language tutorial programs in less commonly taught languages, including, among other things, Spanish and Japanese, provided to individual students as well as to companies and other organizations; and Gaokao repeater tutorial programs, provided to individual students.

About OGEN Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

Share on Social Networks: